A carregar...

Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer’s disease

Several potential disease-modifying drugs for Alzheimer’s disease (AD) have failed to show any effect on disease progression in clinical trials, conceivably because the AD subjects are already too advanced to derive clinical benefit from treatment and because diagnosis based on clinical criteria alo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Alzheimers Dement
Main Authors: Blennow, Kaj, Dubois, Bruno, Fagan, Anne M., Lewczuk, Piotr, de Leon, Mony J., Hampel, Harald
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4386839/
https://ncbi.nlm.nih.gov/pubmed/24795085
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jalz.2014.02.004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!